MLchartDataset catalogue

leridistim

Term · Oncology and biomedicine · MLC-T-ONC-004786

  1. A substance being studied for its ability to stimulate the production of blood cells during chemotherapy. It is a type of colony-stimulating factor. Also called SC-70935.

  2. A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptors, thereby stimulating the production and maturation of neutrophils, platelets, and lymphocytes after chemotherapy.

Table 1. Record
IdentifierMLC-T-ONC-004786
FieldOncology and biomedicine
AbbreviationMPO
SynonymsSC-70935; Myelopoietin
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-004786",
  "term": "leridistim",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance being studied for its ability to stimulate the production of blood cells during chemotherapy. It is a type of colony-stimulating factor. Also called SC-70935.",
    "A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptors, thereby stimulating the production and maturation of neutrophils, platelets, and lymphocytes after chemotherapy."
  ],
  "abbreviation": "MPO",
  "synonyms": [
    "SC-70935",
    "Myelopoietin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/leridistim/"
}

Record 10,024 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.